MARTINIQUE LEWIS: Open Payments
NPI 1851919708 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,625 in 76 payments from 26 companies in 2025. Trend: 2023 $550 · 2024 $228 · 2025 $1,625
Food & beverage: $1,526Education: $99
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 9 | $270 |
| Novo Nordisk Inc | 12 | $152 |
| ABBVIE INC. | 7 | $143 |
| NxStage Medical, Inc. | 1 | $141 |
| Axsome Therapeutics, Inc. | 7 | $125 |
| Bard Peripheral Vascular, Inc. | 1 | $117 |
| Corcept Therapeutics | 4 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
Products named: XYWAV, NXSTAGE SYSTEM ONE, VRAYLAR, Wegovy, Sunosi, Korlym, Rybelsus, JARDIANCE.
Industry payments across VA — which companies pay providers there.
